Group 1 - Huibo Yuntong plans to acquire 65.47% of Baode Computer System shares through a share issuance and has received acceptance from the Shenzhen Stock Exchange for its application [1] - Mingyang Smart Energy intends to purchase 100% of Dehua Chip's equity through a combination of share issuance and cash payment, with stock resuming trading on January 23, 2026 [2] - Sanhua Intelligent Control's controlling shareholder and board members plan to reduce their holdings by up to 0.2425% of the company's shares [3] Group 2 - Wuchan Jinlun's shareholder plans to reduce holdings by up to 3% of the company's total shares [4] - Chengdu Road and Bridge expects a net loss of 65 million to 97.5 million yuan for 2025, compared to a loss of 92.17 million yuan in the previous year [5] - Guoxin Technology anticipates a net loss of 238 million yuan for 2025, an increase in loss of 56.97 million yuan compared to the previous year [6] Group 3 - Taiankang's subsidiary received approval for a clinical trial of CKBA ointment for treating vitiligo in children aged 2-12 [7] - Boyun New Materials' shareholder plans to reduce holdings by up to 1% of the company's total shares [8] - *ST Shengwu has terminated its major asset restructuring plan and expects a net profit of 28.5 million to 32.5 million yuan for 2025, compared to a loss of 19.84 million yuan in the previous year [9] Group 4 - Junchen Technology's shareholder plans to reduce holdings by up to 2.94% of the company's shares [10] - Haiguang Information's shareholder plans to reduce holdings by up to 0.5% of the company's shares [11] - ST Juewei expects a net loss of 160 million to 220 million yuan for 2025, compared to a profit of 227 million yuan in the previous year [12] Group 5 - Nanjing Bank reported total assets exceeding 3 trillion yuan by the end of 2025, with a revenue of 55.54 billion yuan, up 10.48% year-on-year [13] - Haitan Ruisheng's shareholders plan to reduce holdings by up to 5% of the company's shares [14] - Zhaoyi Innovation expects a net profit of approximately 1.61 billion yuan for 2025, a year-on-year increase of about 46% [15] Group 6 - Xiangrikui is discussing a repayment arrangement for a deposit of 40 million yuan with Shanghai Xipu Technology [16] - Yinglian Co. signed a strategic agreement with LG Chem to develop new polymer materials for lithium battery applications [17] - Yingfang Micro expects a net loss of 69 million to 97 million yuan for 2025, compared to a loss of 61.97 million yuan in the previous year [18] Group 7 - Heshun Electric's shareholders plan to reduce holdings by up to 3.5% of the company's shares [20] - Guanghua Technology expects a net profit of 85 million to 120 million yuan for 2025, reversing a loss of 205 million yuan in the previous year [21] - Ruichuang Weina anticipates a net profit of approximately 1.1 billion yuan for 2025, a year-on-year increase of about 93% [22] Group 8 - Huatu Mountain Ding's shareholder plans to reduce holdings by up to 3% of the company's shares [23] - Yinfeng Storage's subsidiary won two procurement projects with a total value of approximately 1.23 billion yuan [24] - Hengyi Petrochemical plans to repurchase shares worth 500 million to 1 billion yuan for employee stock ownership plans [25] Group 9 - Mengcao Ecology's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [26] - Tefa Service's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Green Alliance Technology's shareholders plan to reduce holdings by up to 4% of the company's shares [28] Group 10 - Yunyi Electric plans to repurchase shares worth 100 million to 150 million yuan for employee stock ownership plans [29] - Dongpeng Beverage plans to invest 1.1 billion yuan in a new production base in Chengdu [30] - Zhongyuan Co. expects a net profit of 139 million to 158 million yuan for 2025, a year-on-year increase of 80% to 105% [31] Group 11 - Qiangyi Co. expects a net profit of 368 million to 399 million yuan for 2025, a year-on-year increase of 57.87% to 71.17% [32] - Guochuang High-tech anticipates a net profit of 16 million to 24 million yuan for 2025, reversing a loss of 49.1 million yuan in the previous year [33] - Yuandong Bio received a drug registration certificate for a pediatric medication [34] Group 12 - Liya Technology expects a net profit of 300 million to 380 million yuan for 2025, reversing a loss of 889 million yuan in the previous year [35] - Dongfeng Co. anticipates a net loss of 390 million to 480 million yuan for 2025, compared to a profit of 29.16 million yuan in the previous year [36] - Huaming Equipment reported a 15.29% year-on-year increase in net profit for 2025 [37] Group 13 - Botong Integrated expects a net profit of 17.19 million to 25.78 million yuan for 2025, reversing a loss from the previous year [38] - Qingsong Co. anticipates a net profit of 130 million to 165 million yuan for 2025, a year-on-year increase of 137.73% to 201.74% [39] - Ruihua Tai's shareholder plans to reduce holdings by up to 3% of the company's shares [41]

1月23日，商业航天概念延续昨日强势表现，截至发稿，巨力索具3连板，中超控股2连板，瑞华泰、 飞沃科技、东方日升、 睿创微纳 20%涨停，拓日新能、雪迪龙、 烽火通信、西部材料等均涨停。 德恩精工逼近20%涨停，乾照光电、信维通信、太力科技等多股涨超10%。 | 代码 | 名称 | : (cle n) | 息金额 | 图中值 | 14.17 | | --- | --- | --- | --- | --- | --- | | 688323 | 瑞华泰 | +20.01% | 3.86 Z | 46.647 | 25.91 | | 301232 | 沃科技 | +20.00% | 13.63 Z | 169.1 Z | 224.92 | | 300118 | 东方日升 | +20.00% | 24.52 Z | 236.7 Z | 20.76 | | 688002 | 睿创微纳 | +20.00% | 16.80 Z | 567.5 C | 123.31 | | 300780 | 德恩精工 | +19.92% | 11.32 Z | 45.91 Z | 31.32 | | 301 282 | 太力科技 | +18 ...

Company and Industry Summary Company: Ruichuang Micro-Nano (睿创微纳) Key Points - **Earnings Forecast**: The company anticipates a net profit attributable to shareholders of 1.1 billion yuan in 2025, representing a year-on-year increase of 93% [1] - **Revenue Growth Drivers**: The growth in revenue is driven by the deployment of chip production capacity, which supports sustained high growth. The increase in the proportion of high-margin products, along with a reduction in R&D and incentive expense ratios, contributes to the full release of performance [1] - **Future Outlook**: The infrared business is expected to continue high growth as the overall production capacity ramps up. The automotive sector is entering a phase of increased output. The RF (radio frequency) business is progressing smoothly with research on satellite and ground terminal applications, with the potential for dual-side support in 2027 [1]

Group 1 - The A-share market saw a rebound in commercial aerospace stocks, with notable increases in share prices for several companies, including Deen Precision Engineering up 18% and Ruichuang Micro-Nano up over 17% [1][2] - Beijing Chuanqiu Space Technology Co., Ltd. announced that actor Huang Jingyu will join the first batch of Chinese commercial space travelers, planning to fly on the domestic reusable manned spacecraft "Chuanqiu No. 1" in 2028, with a ticket price of 3 million yuan [1] Group 2 - The stock performance of various companies in the commercial aerospace sector includes: - Deen Precision Engineering (300780) with a market cap of 4.517 billion yuan and a year-to-date increase of 59.75% [2] - Ruichuang Micro-Nano (688002) with a market cap of 55.6 billion yuan and a year-to-date increase of 19.88% [2] - Feiwo Technology (301232) with a market cap of 16.4 billion yuan and a year-to-date increase of 29.45% [2] - Other companies like Liujin Technology, Ruihua Tai, and Tianhe Energy also showed significant gains, with increases ranging from 10% to over 12% [1][2]

Core Viewpoint - The commercial aerospace sector in the A-share market is experiencing a rebound, with significant stock price increases for various companies following the announcement of China's first commercial space tourism initiative [1] Group 1: Stock Performance - Deen Precision Engineering (德恩精工) saw an increase of 18.01%, with a total market capitalization of 4.517 billion [2] - Ruichuang Micro-Nano (睿创微纳) rose by 17.59%, reaching a market cap of 55.6 billion [2] - Feiwo Technology (飞沃科技) increased by 16.28%, with a market value of 1.64 billion [2] - Other notable performers include: - Liujin Technology (流金科技) up 12.61% with a market cap of 4.002 billion [2] - Ruihua Tai (瑞华泰) up 12.41% with a market cap of 4.369 billion [2] - Trina Solar (天合光能) up 11.01% with a market cap of 46.5 billion [2] - Taili Technology (太力科技) up 10.76% with a market cap of 6.643 billion [2] - Qian Zhao Optoelectronics (乾照光电) up 10.63% with a market cap of 33.2 billion [2] - Xuanji Information (旋极信息) up 10.25% with a market cap of 11.5 billion [2] - Zhongchao Holdings (中超控股) up 10.03% with a market cap of 11.7 billion [2] - Ju Li Sockets (巨力索具) up 9.99% with a market cap of 13 billion [2] - Chunhui Intelligent Control (春晖智控) up 9.55% with a market cap of 6.104 billion [2] - Shanghai Port Bay (上海港湾) up 8.44% with a market cap of 15.9 billion [2] - Xinke Mobile (信科移动) up 8.23% with a market cap of 68.3 billion [2] - Xinwei Communication (信维通信) up 7.53% with a market cap of 84.3 billion [2] - Goldwind Technology (金风科技) up 7.36% with a market cap of 122 billion [2] - Western Materials (西部材料) up 7.10% with a market cap of 20.7 billion [2] Group 2: Space Tourism Announcement - Beijing Chuanqiu Space Technology Co., Ltd. announced the inclusion of actor Huang Jingyu in China's first commercial space travel lineup, planning to fly in 2028 aboard the domestic reusable spacecraft "Chuanqiu No. 1" [1] - The flight will last approximately 2.5 hours, crossing the Kármán line at 100 kilometers, allowing for 12 minutes of weightlessness [1] - The ticket price is set at 3 million, requiring a 10% deposit and completion of professional training [1]

商业航天概念持续活跃，消息面上，1月22日，北京穿越者载人航天科技有限公司举行"太空旅游全球发 布会"，国内首艘商业载人飞船"穿越者壹号（CYZ1）"全尺寸试验舱首次公开展示。"穿越者壹号 （CYZ1）"技术团队会前表示，目前已预订了超三艘飞船的座位，合计20余位太空游客，预计2028年将 实现载人首飞。 截至2026年1月23日 09:44，中证国防指数(399973)上涨0.70%，成分股睿创微纳上涨15.98%，西部材料 上涨8.03%，臻镭科技上涨5.30%，国博电子上涨4.41%，航天电子上涨3.64%。国防ETF(512670)上涨 0.58%， 冲击3连涨。最新价报1.04元。 国防ETF紧密跟踪中证国防指数，中证国防指数选取隶属于十大军工集团公司旗下的上市公司证券，以 及为国家武装力量提供武器装备，或与军方有实际装备承制销售金额或签订合同的相关上市公司证券作 为指数样本，以反映国防产业上市公司证券的整体表现。 数据显示，截至2025年12月31日，中证国防指数(399973)前十大权重股分别为航天电子、航发动力、中 航沈飞、中航光电、菲利华、睿创微纳、中航西飞、西部超导、中航机载、海格通信，前 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688002证券简称：睿创微纳公告编号：2026-008 转债代码：118030转债简称：睿创转债 烟台睿创微纳技术股份有限公司 第四届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 烟台睿创微纳技术股份有限公司（简称"公司"）第四届董事会第二次会议于2026年1月22日上午10点在 公司会议室以现场结合通讯方式召开。会议通知于2026年1月19日以电子邮件方式发出，会议应出席董 事7人，实际出席董事7人。 本次会议由公司董事长马宏先生召集并主持，会议的召集及召开程序符合《中华人民共和国公司法》 （以下简称"《公司法》"）等有关法律、法规及规范性法律文件和《公司章程》的有关规定。 二、董事会会议审议情况 本次会议到会董事经过审议，以记名投票表决方式进行表决，最终通过了如下议案： （一）审议通过《关于调整2020年限制性股票激励计划授予价格的议案》 （二）审议通过《关于作废部分已授予尚未归属的限制性股票的议案》 根据 ...

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]